We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Audit: One-Third of Variations Notices Denied Under New EU Regulations
MHRA Audit: One-Third of Variations Notices Denied Under New EU Regulations
September 16, 2010
Roughly 36 percent of Type 1A notifications of variations to marketing authorizations (MAs) in the UK have been rejected on the basis that they were incomplete or otherwise failed to meet new EU regulations that took effect Jan. 1, according to an audit report.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor